Review

Complementary therapy to target LDL cholesterol: the role of the ezetimibe/simvastatin combination.

Vasc Health Risk Manag. 2006 Jan 1;2(1):31-8.
Comparative Study

Changes in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapy.

Vasc Health Risk Manag. 2013 Jan 1;9:719-27.
Article

Evaluating cardiovascular event reduction with ezetimibe as an adjunct to simvastatin in 18,144 patients after acute coronary syndromes: final baseline characteristics of the IMPROVE-IT study population.

Am. Heart J. 2014 Aug 1;168(2):205-12.e1.